FDA有关取消行业突破性治疗指定指南的注意事项(草案)

2022-06-01 美国食品和药品监督管理局 FDA

FDA有关取消行业突破性治疗指定指南的注意事项

中文标题:

FDA有关取消行业突破性治疗指定指南的注意事项(草案)

英文标题:

Considerations for Rescinding Breakthrough Therapy Designation Guidance for Industry

发布日期:

2022-06-01

简要介绍:

FDA有关取消行业突破性治疗指定指南的注意事项

相关资料下载:
[AttachmentFileName(sort=1, fileName=1.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1d8a61c0025663a3, title=FDA有关取消行业突破性治疗指定指南的注意事项(草案), enTitle=Considerations for Rescinding Breakthrough Therapy Designation Guidance for Industry, guiderFrom=FDA, authorId=0, author=, summary=FDA有关取消行业突破性治疗指定指南的注意事项, cover=, journalId=0, articlesId=null, associationId=486, associationName=美国食品和药品监督管理局, associationIntro=美国食品和药品监督管理局是美国公共卫生及服务部的一个代理商,其由委员会办公室和4个监督核心功能理事机构组成。, copyright=0, guiderPublishedTime=Wed Jun 01 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p>FDA有关取消行业突破性治疗指定指南的注意事项</p>, tagList=[TagDto(tagId=87046, tagName=突破性治疗指定)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=30, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=625, appHits=4, showAppHits=0, pcHits=74, showPcHits=621, likes=0, shares=1, comments=0, approvalStatus=1, publishedTime=Mon Aug 08 17:38:00 CST 2022, publishedTimeString=2022-06-01, pcVisible=1, appVisible=1, editorId=0, editor=小小医者, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=小小医者, createdTime=Fri Aug 05 09:40:04 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Thu Jan 04 23:58:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=1.pdf)])
1.pdf
下载请点击:
评论区 (0)
#插入话题